Sanger Institute Purchases PacBio RS Single-Molecule Sequencer | GenomeWeb

The Wellcome Trust Sanger Institute has purchased a PacBio RS single-molecule sequencer as part of an expansion of Pacific Biosciences’ early-access program, the company said this week.

Earlier this year, PacBio named its first 10 early-access customers (IS 2/23/2010), all located in North America, several of who have received their instruments.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.